Knee Osteoarthritis Clinical Trial
Official title:
Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur With Cruciate Sacrificing Inserts
Verified date | March 2024 |
Source | MicroPort Orthopedics Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® BIOFOAM® Tibia and EVOLUTION® Cruciate Sacrificing/Cruciate Retaining (CS/CR) Porous Femur components, including EVOLUTION® CS tibial inserts. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.
Status | Active, not recruiting |
Enrollment | 150 |
Est. completion date | August 2032 |
Est. primary completion date | February 2032 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: 1. Has previously undergone or currently has determined to undergo a primary TKA with the specified combination of components: EVOLUTION® CS/CR Porous Femur, EVOLUTION® CS Tibial Insert, and EVOLUTION® BIOFOAM® Tibia and modular keel 2. Has previously undergone or currently has determined to undergo a primary TKA for any of the following: - non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis; - inflammatory degenerative joint disease including rheumatoid arthritis; - correction of functional deformity; - willing and able to complete required study visits and assessments through the 10 year postoperative follow-up visit. 3. Previously implanted subjects must be enrolled within 3 years (+6 months) of their primary TKA implantation Exclusion Criteria: 1. Skeletally immature (less than 21 years of age) at time of implantation 2. Has or had an overt infection at the time of implantation 3. Has or had a distant foci of infections (which may cause hematogenous spread to the implant site) at the time of implantation 4. Has or had a rapid disease progression as manifested by joint destruction or bone absorption apparent on roentgenogram at the time of implantation 5. Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable 6. Has had a revision procedure(s) where other treatments or devices have failed; and treatment of fractures that are unmanageable using other techniques 7. Currently enrolled in another clinical investigation which could affect the endpoints of this protocol 8. Unwilling or unable to sign the Informed Consent document 9. Has documented substance abuse issues 10. Has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study 11. Currently incarcerated or has impending incarceration 12. Has a medical condition, as judged by the Investigator, that would interfere with the subject's ability to comply with the requirements of the protocol |
Country | Name | City | State |
---|---|---|---|
United States | Covenant Medical Center | Saginaw | Michigan |
Lead Sponsor | Collaborator |
---|---|
MicroPort Orthopedics Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Individual component survivorship | Individual component survivorship for tibial base, femoral, and tibial CS insert at specified intervals out to 10 years follow-up. | 10 years post-operative | |
Secondary | Patient Reported Outcomes- Knee Injury and Osteoarthritis Outcome Scores | -functional scores for subjects, as assessed by Knee Injury and Osteoarthritis Outcome Score (KOOS), out to 10 years follow-up | 10 years post-operative | |
Secondary | Patient Reported Outcomes- EuroQol-5D-5L Scores | -functional scores for subjects, as assessed by EuroQol-5D-5L (EQ-5D-5L) Scores, out to 10 years follow-up | 10 years post-operative | |
Secondary | Patient Reported Outcomes- Forgotten Joint Score | -subject satisfaction measures with their Total Knee Arthroplasty (TKA) procedure using the Forgotten Joint Score | 10 years post-operative | |
Secondary | Patient Reported Outcomes- Satisfaction Survey | -subject satisfaction measures with their Total Knee Arthroplasty (TKA) procedure using the Satisfaction Survey | 10 years post-operative | |
Secondary | Incidence of component revision | the cumulative incidence of component revision at specified intervals will be determined out to 10 years follow-up | 10 years post-operative | |
Secondary | Radiolucencies | the presence, zone, and the size of radiolucencies surrounding implanted components will be determined | 10 years post-operative | |
Secondary | Adverse Events and Adverse Device Effects | characterization of adverse events and adverse device effects | 10 years post-operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |